These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Bastard JP; Caron M; Vidal H; Jan V; Auclair M; Vigouroux C; Luboinski J; Laville M; Maachi M; Girard PM; Rozenbaum W; Levan P; Capeau J Lancet; 2002 Mar; 359(9311):1026-31. PubMed ID: 11937183 [TBL] [Abstract][Full Text] [Related]
27. Risk factors in human immunodeficiency virus/acquired immunodeficiency syndrome patients undergoing antiretroviral therapy in the state of Pernambuco, Brazil: a case-control study. Gelenske T; e Farias FA; de Alencar Ximenes RA; de Melo HR; de Albuquerque Mde F; de Carvalho EH; de Medeiros Barros Z; Diniz GT; Filho Dde B Metab Syndr Relat Disord; 2010 Jun; 8(3):271-7. PubMed ID: 20158442 [TBL] [Abstract][Full Text] [Related]
28. A new era of antiretroviral drug toxicity. Calmy A; Hirschel B; Cooper DA; Carr A Antivir Ther; 2009; 14(2):165-79. PubMed ID: 19430091 [TBL] [Abstract][Full Text] [Related]
29. Considering metabolic issues when initiating HIV therapy. Wohl DA Curr HIV/AIDS Rep; 2007 Aug; 4(3):119-25. PubMed ID: 17883997 [TBL] [Abstract][Full Text] [Related]
30. [Lipodystrophies related to antiretroviral treatment of HIV infection]. Capeau J; Caron M; Vigouroux C; Cervera P; Kim M; Maachi M; Lagathu C; Bastard JP Med Sci (Paris); 2006 May; 22(5):531-6. PubMed ID: 16687123 [TBL] [Abstract][Full Text] [Related]
31. [Metabolic changes in HIV infected patient]. Castelo Filho A; Abrão P Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):5-7. PubMed ID: 17435849 [No Abstract] [Full Text] [Related]
32. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome. Barbaro G Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554 [TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. Zanone Poma B; Riva A; Nasi M; Cicconi P; Broggini V; Lepri AC; Mologni D; Mazzotta F; Monforte AD; Mussini C; Cossarizza A; Galli M; AIDS; 2008 Sep; 22(14):1769-78. PubMed ID: 18753860 [TBL] [Abstract][Full Text] [Related]
34. No relationship between TNF-α genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis. Veloso S; Olona M; Peraire J; Viladés C; Pardo P; Domingo P; Asensi V; Broch M; Aguilar C; López-Dupla M; Aragonés G; Garcia-Pardo G; Sirvent JJ; Vendrell J; Richart C; Vidal F; AIDS Res Hum Retroviruses; 2011 Feb; 27(2):143-52. PubMed ID: 20854131 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271 [TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in adiponectin receptor genes are associated with lipodystrophy-related phenotypes in HIV-infected patients receiving antiretroviral therapy. Castilhos JK; Sprinz E; Lazzaretti RK; Kuhmmer R; Mattevi VS HIV Med; 2015 Sep; 16(8):494-501. PubMed ID: 26111083 [TBL] [Abstract][Full Text] [Related]
37. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation. Parra S; Coll B; Aragonés G; Marsillach J; Beltrán R; Rull A; Joven J; Alonso-Villaverde C; Camps J HIV Med; 2010 Apr; 11(4):225-31. PubMed ID: 19845792 [TBL] [Abstract][Full Text] [Related]
38. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy. Calza L; Manfredi R; Pocaterra D; Chiodo F J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. Grinspoon S; Carr A N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112 [No Abstract] [Full Text] [Related]
40. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells. Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]